Primary tumor cells and tumor-associated macrophages (TAMs) from ovarian tumors produced CCL22, a ligand for CCR4, which was crucial for the migration Tregs, whose CCR4 expression was higher than other CD4+ T cells [86]. This evidence concerns the gene CCL22 and neoplasm.